Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
ATHA logo

ATHA

NSC
Athira Pharma Inc.
ManufacturingBiological Product (except Diagnostic) Manufacturing
Watchlists:
Last updated: Tuesday 15th July 2025
0.41
+0.00 (1.09%)
Prev Close:0.4023
Open:0.405
Bid:0.4068
Ask:0.415
52 Week Range
0.22
3.67
Volume:547,608
Mkt Cap:14 M
Price Target
$0.47
+15.6%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

ATHA - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Invalid date
Depreciation And Amortization970000.0969000.0845000.0479000.02000.0
General And Administrative Expense26 M33 M33 M21 M7 M
Interest Expense Non Operating3000.0367000.0
Misc Other Special Charges4 M8 M3 M334000.0-1 M
Net Income (loss)-97 M-118 M-96 M-55 M-20 M
Net Income Common Stockholders-97 M-118 M-96 M-55 M-20 M
Net Income Continuous Operations-97 M-118 M-96 M-55 M-20 M
Net Income From Other Gains Losses5 M9 M1 M
Net Non Operating Interest Income Expense334000.0-243000.0
Non Recurring Operation Expense4 M-2 M10 M
Normalized Income-89 M
Operating Income-101 M-125 M-104 M-64 M-20 M
Operating Income Before Depreciation (EBITDA)-96 M-116 M-88 M-55 M-20 M
Operating Expense97 M127 M89 M64 M20 M
Other Gand A26 M33 M33 M21 M7 M
Other Operating Expenses-1 M-2 M-684000.0323000.085000.0
Research Expense71 M94 M61 M43 M13 M
Restructring And Mn A Income3 M
Salaries And Wages11 M11 M
Total Income Available For Interest Expense (EBIT)-97 M-118 M-89 M-55 M-20 M
Total Expenses97 M127 M89 M64 M20 M
Avgshs38 M38 M38 M37 M12 M
Avgshsdt38 M38 M38 M37 M12 M
Basiceps-2.52-3.09-2.53-1.49-1.67
Basicepscont-2.52-3.09-2.53-1.49-1.67
Depamor970000.0969000.0845000.0479000.02000.0
Dileps-2.52-3.09-2.53-1.49-1.67
Dilepscont-2.52-3.09-2.53
Intinc337000.0124000.0
Netincdisc-97 M-118 M-96 M-55 M-20 M
Othincexp-4 M-8 M-7 M-334000.01 M
Pretaxinc-97 M-118 M-96 M-64 M-21 M
Resdev71 M94 M61 M43 M13 M
Restruct3 M
Sga26 M33 M33 M21 M7 M
Shsout39 M38 M38 M38 M37 M
Specincchg-4 M2 M-10 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader